NCT00691652 2019-11-27Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin LymphomaOHSU Knight Cancer InstitutePhase 1/2 Terminated2 enrolled 4 charts
NCT01383447 2017-08-08Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Terminated2 enrolled 4 charts